Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma

NCT00004088 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: recombinant interferon alfa
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: melphalan
DRUG: pamidronate disodium
DRUG: thalidomide
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

City of Hope Medical Center

Collaborators

[object Object]